Literature DB >> 22267113

[Pregestational overweight and obesity: prevalence and outcome associated with pregnancy].

Gisele Seabra1, Patricia de Carvalho Padilha, Juliana Agrícola de Queiroz, Cláudia Saunders.   

Abstract

PURPOSE: To describe the obstetric outcome of women with overweight/obesity treated at the prenatal care clinic of a public maternity hospital in Rio de Janeiro.
METHODS: A descriptive cross-sectional study which investigated 433 women (≥20 years-old, without any chronic diseases) and their newborns treated at public hospitals in Rio de Janeiro. Information was collected from medical records and through interviews. The characteristics of mothers and newborns evaluated were divided into maternal (social habits, anthropometric measurements and clinical, obstetric, and prenatal care) and newborn groups (birth conditions). Data regarding the categories of nutritional status were analyzed using the odds ratio (OR) and 95% confidence interval (CI).
RESULTS: The prevalence of overweight/obesity in this sample was 24.5% (n=106). There was an association between inadequate weight gain and the prevalence of overweight/obesity (OR 2.7, 95%CI 1.5-4.9, p<0.05). Overweight/obese women had an increased risk for preeclampsia (OR 3.3, 95%CI 1.1--9.9, p=0.03). Regarding birth conditions, mean birth weight was 3291.3 g (±455.2), with rates of low birth weight of 4.7% (n=5) and rates of macrosomia of 2.8% (n=3).
CONCLUSIONS: There was an alarming prevalence of inadequate nutritional status before and during pregnancy, which may be associated with increased risk of perinatal morbidity and mortality. This suggests the need for nutritional monitoring of these pregnant women.

Entities:  

Mesh:

Year:  2011        PMID: 22267113

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  7 in total

1.  Pregnancy after Bariatric Surgery: Obstetric and Perinatal Outcomes and the Growth and Development of Children.

Authors:  Cátia Millene Dell'Agnolo; Caroline Cyr; Francine de Montigny; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 2.  Interventions to prevent adverse fetal programming due to maternal obesity during pregnancy.

Authors:  Peter W Nathanielsz; Stephen P Ford; Nathan M Long; Claudia C Vega; Luis A Reyes-Castro; Elena Zambrano
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

Review 3.  Vitamin D deficiency in pregnancy after bariatric surgery.

Authors:  Marina Medeiros; Cláudia Saunders; Cristiane B Chagas; Silvia E Pereira; Carlos Saboya; Andréa Ramalho
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

4.  Association between maternal glucose levels during pregnancy and gestational diabetes mellitus: an analytical cross-sectional study.

Authors:  Gisele Seabra; Cláudia Saunders; Patrícia de Carvalho Padilha; Lenita Zajdenverg; Letícia Barbosa Gabriel da Silva; Marta Maria Antonieta de Souza Santos
Journal:  Diabetol Metab Syndr       Date:  2015-03-12       Impact factor: 3.320

5.  Pregestational body mass index, weight gain during pregnancy and perinatal outcome: a retrospective descriptive study.

Authors:  Lais Assenheimer de Paula Ferreira; Carla de Azevedo Piccinato; Eduardo Cordioli; Eduardo Zlotnik
Journal:  Einstein (Sao Paulo)       Date:  2019-11-07

6.  Maternal Factors and Adverse Perinatal Outcomes in Women with Preeclampsia in Maceió, Alagoas.

Authors:  Alane Cabral Menezes de Oliveira; Arianne Albuquerque Santos; Alexandra Rodrigues Bezerra; Amanda Maria Rocha de Barros; Myrian Cicyanne Machado Tavares
Journal:  Arq Bras Cardiol       Date:  2016-01-15       Impact factor: 2.000

7.  Association between excessive maternal weight, periodontitis during the third trimester of pregnancy, and infants' health at birth.

Authors:  Gerson Aparecido Foratori-Junior; Bruno Gualtieri Jesuino; Rafaela Aparecida Caracho; Eliel Soares Orenha; Francisco Carlos Groppo; Silvia Helena de Carvalho Sales-Peres
Journal:  J Appl Oral Sci       Date:  2020-03-27       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.